Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients.

Literature DB >> 17426437

Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients.

Linda Meade-Tollin¹, Jesse D Martinez.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2007 PMID： 17426437 DOI： 10.4161/cbt.6.2.4024

Source DB: PubMed Journal: Cancer Biol Ther ISSN： 1538-4047 Impact factor: 4.742

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.

Authors: Yong Liu; Changyun Yu; Yuanzheng Qiu; Donghai Huang; Xiaojuan Zhou; Xin Zhang; Yongquan Tian
Journal: J Cancer Res Clin Oncol Date: 2011-11-16 Impact factor: 4.553

2. Crystallization and preliminary X-ray diffraction analysis of the complex of a human anti-ephrin type-A receptor 2 antibody fragment and its cognate antigen.

Authors: Vaheh Oganesyan; Melissa M Damschroder; Sandrina Phipps; Susan D Wilson; Kimberly E Cook; Herren Wu; William F Dall'Acqua
Journal: Acta Crystallogr Sect F Struct Biol Cryst Commun Date: 2010-05-29

Review 3. Current approaches to fine mapping of antigen-antibody interactions.

Authors: W Mark Abbott; Melissa M Damschroder; David C Lowe
Journal: Immunology Date: 2014-08 Impact factor: 7.397

4. Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.

Authors: Elizabeth M Bruckheimer; Christine A Fazenbaker; Sandra Gallagher; Kathy Mulgrew; Stacy Fuhrmann; Karen T Coffman; William Walsh; Shannon Ready; Kim Cook; Melissa Damschroder; Michael Kinch; Peter A Kiener; Rob Woods; Changshou Gao; William Dall'Acqua; Herren Wu; Steven Coats
Journal: Neoplasia Date: 2009-06 Impact factor: 5.715

Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients.

1. Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivo.

2. Crystallization and preliminary X-ray diffraction analysis of the complex of a human anti-ephrin type-A receptor 2 antibody fragment and its cognate antigen.

Review 3. Current approaches to fine mapping of antigen-antibody interactions.

4. Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.

Review 5. Therapeutic advances in women's cancers.

6. Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: an immunohistochemical study.

7. Bi-epitope SPR surfaces: a solution to develop robust immunoassays.